Immune Pathways & Development of Sarcoidosis

Trial Objective

Epigenetic Regulation of Immune Pathways in SarcoidosisThe purpose of this study is to learn more about patients who have sarcoidosis and those who do not in order to define different types of sarcoidosis and what may predict how the disease develops over time.


New enrollment for this trial is temporarily paused

Who Can Participate

Adult nonsmokers who have biopsy-proven sarcoidosis and who are not on immunosuppressive therapy may be eligible to participate.

Adult nonsmokers who do not have an autoimmune disease and/or presence of any other serious disease and who are not on immunosuppressive therapy may be eligible to participate.

Age: 18+    Gender: Any Gender

Estimated Time Commitment

Up to 2 visits

One blood draw and one bronchoscopy, a procedure that allows doctors to examine your airways.

Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Christina Riley

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Institutes of Health

Principal Investigators

Request More Information

Due to concerns around COVID-19 and our focus on helping to meet this momentous challenge, we have temporarily paused enrollment for all trials requiring an in-person visit. Please feel free to request additional information about any of the trials we have posted and we will get back to you when enrollment resumes. For more resources and information on COVID-19 please visit our special coronavirus website at